Public annual accounts

DIAGENODE financials

Name: DIAGENODE financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for DIAGENODE, with comparable measures and links to available source documents.

Company overview

Registry number

0480422786

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for DIAGENODE

2025 versus 2024

Operating line: €11,857,386
EBITDA: -€761,770
Total assets: €21,058,962
Equity: €8,701,475

EBITDA margin -6.4% · Equity ratio +41.3%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Revenue	EBITDA	Total assets	Equity	Filing
202530 Sept 2025	€11,857,386	-€761,770	€21,058,962	€8,701,475	-
202430 Sept 2024	€13,050,694	€2,301,588	€22,342,633	€12,018,173	-

Revenue line derived from reported turnover.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report